Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Parkinson's Disease: Overview01:15

Parkinson's Disease: Overview

1.7K
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
1.7K
Model Approaches for Pharmacokinetic Data: Distributed Parameter Models01:06

Model Approaches for Pharmacokinetic Data: Distributed Parameter Models

240
Pharmacokinetic models are mathematical constructs that represent and predict the time course of drug concentrations in the body, providing meaningful pharmacokinetic parameters. These models are categorized into compartment, physiological, and distributed parameter models.
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...
240
Parkinson's Disease: Treatment01:24

Parkinson's Disease: Treatment

972
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
972
Longitudinal Studies01:26

Longitudinal Studies

473
Longitudinal studies are also widely used in other medical and social science fields. For instance, in cardiovascular research, they can monitor patients' health over decades to identify risk factors for heart disease, such as high cholesterol or smoking, and evaluate the long-term effectiveness of preventive measures. Similarly, in mental health studies, researchers might follow individuals from adolescence into adulthood to understand the development and progression of conditions like...
473
Multicompartment Models: Overview01:14

Multicompartment Models: Overview

497
Multicompartment models are mathematical constructs that depict how drugs are distributed and eliminated within the body. They segment the body into several compartments, symbolizing various physiological or anatomical areas connected through drug transfer processes such as absorption, metabolism, distribution, and elimination.
These models offer a more comprehensive representation of drug behavior in the body than one-compartment models. They accommodate the complexity of drug distribution,...
497
Model Approaches for Pharmacokinetic Data: Physiological Models01:15

Model Approaches for Pharmacokinetic Data: Physiological Models

246
Physiological models in pharmacokinetics are instrumental in understanding the distribution and elimination of drugs within the body. These models describe the drug concentration within target organs, influenced by factors such as drug uptake, tissue volume, and blood flow. Drug uptake is governed by the partition coefficient, which signifies the drug concentration ratio in tissue to that in the blood. The blood flow rate to a specific tissue is expressed as Qt, and the rate of change in tissue...
246

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Erythrocyte Count, Anemia, and the Human Natural Lifespan Limit: Evidence from the Long Life Family Study.

bioRxiv : the preprint server for biology·2026
Same author

Longitudinal Sparse Single-Omics Factor Analysis for High-Dimensional Blood Biomarkers in Alzheimer's Disease.

Statistics in medicine·2026
Same author

Deep learning for the joint analysis of item-level longitudinal and survival data.

Journal of applied statistics·2026
Same author

Exploration of Optimal Synergistic Treatment Strategies of Postoperative Radiotherapy and Immunotherapy in Early-Stage Breast Cancer.

Cancers·2026
Same author

Joint modeling of high-dimensional longitudinal data and survival using supervised low-rank tensor decomposition.

Biostatistics (Oxford, England)·2026
Same author

Comprehensive Analysis and Prediction of HER2-Targeted Therapy Insensitivity Among HER2-Positive Breast Cancer Patients Undergoing Neoadjuvant Treatment.

Cancers·2026

Related Experiment Video

Updated: Jan 14, 2026

Dynamic Digital Biomarkers of Motor and Cognitive Function in Parkinson's Disease
10:28

Dynamic Digital Biomarkers of Motor and Cognitive Function in Parkinson's Disease

Published on: July 24, 2019

15.9K

Dynamic Prediction Using Functional Latent Trait Joint Models for Multivariate Longitudinal Outcomes: An Application

Mohammad Samsul Alam1, Dongrak Choi1, Salil Koner1

  • 1Department of Biostatistics and Bioinformatics, Duke University, Durham, North Carolina, USA.

Statistics in Medicine
|October 17, 2025
PubMed
Summary

This study introduces a new model (FLTM-JM) to analyze complex Parkinson's disease (PD) data, integrating symptom progression and survival outcomes for better patient insights and personalized treatment strategies.

Keywords:
Bayesian inferencedisease progressionfunctional data analysispersonalized medicinesurvival analysis

More Related Videos

Gene-environment Interaction Models to Unmask Susceptibility Mechanisms in Parkinson's Disease
08:09

Gene-environment Interaction Models to Unmask Susceptibility Mechanisms in Parkinson's Disease

Published on: January 7, 2014

7.9K
Identification of Disease-related Spatial Covariance Patterns using Neuroimaging Data
14:27

Identification of Disease-related Spatial Covariance Patterns using Neuroimaging Data

Published on: June 26, 2013

16.1K

Related Experiment Videos

Last Updated: Jan 14, 2026

Dynamic Digital Biomarkers of Motor and Cognitive Function in Parkinson's Disease
10:28

Dynamic Digital Biomarkers of Motor and Cognitive Function in Parkinson's Disease

Published on: July 24, 2019

15.9K
Gene-environment Interaction Models to Unmask Susceptibility Mechanisms in Parkinson's Disease
08:09

Gene-environment Interaction Models to Unmask Susceptibility Mechanisms in Parkinson's Disease

Published on: January 7, 2014

7.9K
Identification of Disease-related Spatial Covariance Patterns using Neuroimaging Data
14:27

Identification of Disease-related Spatial Covariance Patterns using Neuroimaging Data

Published on: June 26, 2013

16.1K

Area of Science:

  • Biostatistics
  • Clinical Informatics
  • Neuroscience

Background:

  • Parkinson's disease (PD) is progressive, requiring analysis of diverse longitudinal data types.
  • Understanding symptom progression and survival outcomes necessitates advanced statistical approaches.
  • Current methods may not fully capture the complexity of multivariate longitudinal and time-to-event data in PD.

Purpose of the Study:

  • To introduce the functional latent trait model-joint model (FLTM-JM) for joint analysis of multivariate longitudinal data and survival outcomes in PD.
  • To provide a flexible framework for modeling complex covariate relationships over time.
  • To enable dynamic, subject-specific predictions for personalized treatment strategies.

Main Methods:

  • Developed a novel joint modeling framework (FLTM-JM) based on the functional latent trait model (FLTM).
  • Utilized a non-parametric, function-on-scalar regression for flexible modeling of longitudinal data.
  • Applied the model to Movement Disorder Society Unified Parkinson's Disease Rating Scale (MDS-UPDRS) data from the Parkinson's Progression Markers Initiative (PPMI).

Main Results:

  • FLTM-JM effectively integrates multivariate longitudinal data and time-to-event outcomes.
  • The model identified key covariate influences on PD progression.
  • Demonstrated the utility of dynamic, subject-specific predictions for clinical decision-making.
  • Simulation studies confirmed accuracy, robustness, and efficiency, even with model misspecification.

Conclusions:

  • FLTM-JM offers a powerful approach for analyzing complex PD data.
  • The framework supports personalized medicine by providing dynamic predictions.
  • This method enhances understanding of disease trajectory and informs clinical management.